EMCDDA–Europol Joint Report on a new psychoactive substance 5-(2-aminopropyl)indole (5-IT)
Introduction
At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.
Download as PDF
Table of contents
- Introduction
- Information collection process
- Information required by Article 5.2 of the Decision
- Information from the EMA as requested by Article 5.3 of the Decision
- Summary of findings
- Conclusions
Annexes
- Annex 1 — Main information sources
- Annex 2 — Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
- Annex 3 — Deaths associated with 5-(2-aminopropyl)indole (5-IT) reported
to the EMCDDA